Company Description
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions.
It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne.
The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016.
STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Country | United States |
Founded | 1989 |
IPO Date | Oct 28, 2005 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 99 |
CEO | Dr. Dolev Rafaeli Ph.D. |
Contact Details
Address: 5 Walnut Grove Drive, Suite 140 Horsham, Pennsylvania 19044 United States | |
Phone | 215-619-3200 |
Website | strataskinsciences.com |
Stock Details
Ticker Symbol | SSKN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001051514 |
CUSIP Number | 86272A206 |
ISIN Number | US86272A2069 |
Employer ID | 13-3986004 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Christopher Lesovitz | Chief Financial Officer |
Shmuel Gov | Chief Operating Officer |
Dr. Dolev Rafaeli Ph.D. | President, Chief Executive Officer and Vice-Chairman |
Jay Sturm | General Counsel and Corporate Secretary |
Michael E. Goodman | Head of International Sales |
Michael R. Stewart | Independent Consultant |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 28, 2024 | 10-K | Annual Report |
Mar 27, 2024 | 8-K | Current Report |
Feb 26, 2024 | 8-K | Current Report |
Feb 21, 2024 | 8-K | Current Report |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Jan 8, 2024 | 8-K | Current Report |
Jan 3, 2024 | 8-K | Current Report |
Dec 29, 2023 | 8-K | Current Report |
Nov 15, 2023 | 8-K | Current Report |
Nov 15, 2023 | 8-K | Current Report |